Related Experiment Video
Updated: Aug 10, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Haemophilia and the newborn
1Department of Haematology, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow G3 8SJ, UK. elizabeth.chalmers@yorkhill.scot.nhs.uk
Diagnosing and managing hemophilia in newborns is challenging due to unique physiological factors and bleeding patterns. Optimal care requires collaboration among obstetricians, hematologists, and neonatologists for safe infant outcomes.
Area of Science:
- Pediatric Hematology
- Neonatal Medicine
- Genetics
Background:
- Inherited bleeding disorders, specifically Hemophilia A and B, are common in newborns.
- Neonatal hemophilia presents unique diagnostic and management challenges compared to older children.
- Physiological differences in the neonatal hemostatic system complicate diagnostic investigations.
Purpose of the Study:
- To highlight the diagnostic and management complexities of hemophilia in newborns.
- To emphasize the importance of multidisciplinary collaboration in managing neonatal hemophilia.
- To discuss the increased risk and management controversies surrounding intracranial hemorrhage in neonates with hemophilia.
Main Methods:
- Review of existing literature on neonatal hemophilia.
- Analysis of diagnostic challenges in neonates versus older children.
- Discussion of management strategies and complications, including intracranial hemorrhage.
Main Results:
- Neonatal hemophilia diagnosis can be delayed due to atypical bleeding presentation and lack of family history.
- Intracranial hemorrhage risk is elevated in the neonatal period due to delivery trauma.
- Optimal management strategies for neonatal hemophilia and its complications remain debated.
Conclusions:
- Effective management of neonatal hemophilia necessitates close cooperation between obstetricians, hematologists, and neonatologists.
- Early recognition of abnormal bleeding and understanding neonatal hemostasis are crucial for diagnosis.
- Further research is needed to establish optimal prevention and management protocols for neonatal intracranial hemorrhage in hemophilia cases.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Rh Blood Group

